Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide free base; timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol free base - eye drops, solution - 20mg/ml, 5mg/ml - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide free base timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol free base excipient: benzalkonium chloride hyetellose mannitol sodium citrate sodium hydroxide water for injection - cosopt is indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hcl and timolol maleate

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml; timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 20mg/ml, 5mg/ml - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride hyetellose mannitol sodium citrate sodium hydroxide water for injection - arrow - dortim is indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hcl and timolol maleate.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml; timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 20 mg/ml + 5 mg/ml - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride hyetellose mannitol sodium citrate sodium hydroxide water for injection - indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · other secondary open-angle glaucoma and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hcl and timolol maleate

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - dorzolamide hydrochloride 22.26 mg/ml equivalent to to dorzolamide 20 mg/ml; timolol maleate 6.83 mg/ml equivalent to to timolol 5 mg/ml - eye drops, solution - 2% / 0.5% - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to to dorzolamide 20 mg/ml timolol maleate 6.83 mg/ml equivalent to to timolol 5 mg/ml excipient: benzalkonium chloride as 50% w/w solution hyetellose mannitol sodium citrate sodium hydroxide water for injection - indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · other secondary open-angle glaucoma and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hcl and timolol maleate

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide; timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol excipient: hyetellose mannitol sodium citrate dihydrate sodium hydroxide water for injection - indicated in the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hydrochloride and timolol maleate.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - dorzolamide hydrochloride,timolol maleate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - dorzolamide hydrochloride,timolol maleate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: water for injections; benzalkonium chloride; hyetellose; mannitol; sodium citrate dihydrate; sodium hydroxide - trusamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - dorzolamide hydrochloride; timolol maleate - eye drops - 20mg/1ml ; 5mg/1ml